G
lucagon, a 29-residue peptide hormone, plays an important role in g
lucose homeostasis andin
diabetes mellitus. Several g
lucagon antagonists and agonists have been developed, but limited structuralinformation is available to clarify the basis of their biological activity. The so
lution structure of the potentg
lucagon antagonist, [desHis
1, desPhe
6, G
lu9]g
lucagon amide, was determined by homonuclear 2D NMRspectroscopy at pH 6.0 and 37
C in perdeuterated dodecylphosphocholine micelles. The overall backboneroot-mean-square deviation (rmsd) for the structured portion (residues 7-29, g
lucagon numbering) of themicelle-bound 27-residue peptide is 1.36 Å for the 15 lowest-energy structures, after restrained moleculardynamics simulation. The structure consists of four regions (segment backbone rmsd in Å): an unstructuredN-terminal segment between residues 2 and 5 (1.68), an irregular helix between residues 7 and 14 (0.79),a hinge region between residues 15 and 18 (0.54), and a well-defined
-helix between residues 19 and 29(0.33). The two helices form an L-shaped structure with an angle of about 90
between the helix axes.There is an extended hydrophobic c
luster, which runs along the inner surface of the L-structure andincorporates the side chains of the hydrophobic residues of each of the amphipathic helices. The outersurface contains the hydrophilic side chains, with two salt bridges (D15-R18 and R17-D21) implied fromclose approach of the charged groups. This result is the first clear indication of an overall tertiary fold fora g
lucagon analogue in the micelle-bound state. The relationship of the two helical structural elementsmay have important implications for the biological activity of the g
lucagon antagonist.